Skip to main content
. 2011 Nov;59(5):975–983. doi: 10.1111/j.1365-2559.2011.04034.x

Figure 5.

Figure 5

Results of competitive enzyme-linked immunosorbent assay (ELISA). Human epidermal growth factor receptor 1 (HER1), HER2 and HER4 peptides were added and competition investigated for the PATHWAY® HER2 antibody (A), the HercepTest™ antibody (B) and the CB11 antibody concentrate (C). The figure shows the result of one experiment representative of three independent ones.